Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

A Jordanian family with Clouston syndrome has a common GJB6 gene mutation.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

The document concludes that the girl's hairlessness is likely inherited from her parents.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

Micropigmentation is a cosmetic tattooing technique for hiding skin issues and creating permanent makeup, but it can have side effects.

A child lost eyelashes on one eyelid after COVID-19, likely due to a temporary hair loss condition.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

Early recognition and treatment of VATS in transplant patients improve outcomes.

The document concludes that specialized hair transplant techniques can be effective, with varying success rates depending on the donor area and patient factors.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

The document concludes that successful treatment of upper and midface trauma should focus on restoring both appearance and function, with attention to facial structure, skin, and hair repair.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Hand-foot-mouth disease may cause nail loss in children.

Hair casts are often mistaken for head lice, scalp pain in hair loss is linked to certain nerve factors, eyelash growth treatment is safe and effective, and nail shedding in children may follow hand-foot-mouth disease.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

The book is a detailed and useful guide for doctors learning about hair transplantation.

The document concludes that using small hair grafts has improved facial and scalp hair restoration.

Single hair follicle transplantation is best for restoring eyelashes, eyebrows, and pubic hair, with attention to natural hair direction, thickness, and design.

Eye drops with β-blockers may cause hair loss.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

The pigment in black eyeliner can spread in the skin and may cause permanent eyelash loss.

Alopecia areata negatively impacts quality of life and work, even with moderate hair loss.